Detail
RLID: | RLID00032688 |
RNA Symbol: | hsa-miR-483-3p |
RNA Category: | miRNA |
Organism: | Homo sapiens |
Aliase: | hsa-miR-483 |
Homology: | hsa-miR-483-5p (Homo sapiens ) |
Subcellular Localization: |
Localization | Tissue | Validated Method | PMID |
Circulating | Plasma | qRT-PCR | 24961598 |
Description: This is the first report of circulating miR biomarkers in LVAD patients. We demonstrate the feasibility of this approach, report the potential for miR-483-3p and miR-1202, respectively, to monitor and predict response to LVAD therapy, and propose further work to study these hypotheses and elucidate roles for miR-483-3p and miR-1202 in clinical practice and in underlying biological processes. |
Other Subcellular Localization:
RLID | Localization | Tissue | Validated Method | PMID |
RLID00032689 | Exosome | Serum | Microarray | 18589210 |
RLID00032690 | Exosome | Saliva | Microarray | 19627513 |
RLID00032691 | Exosome | Primary dendritic cell | Microarray | 21505438 |
RLID00032692 | Exosome | Malignant melanoma cell | Microarray | 23056502 |
RLID00032693 | Exosome | Brain tissue | Microarray | 23382797 |
RLID00032694 | Exosome | K562 cell | Microarray | 24460325 |
RLID00032695 | Mitochondrion | Skeletal muscular cell | In situ hybridization|qRT-PCR | 21637849 |
RLID00032696 | Exosome | Follicular cell | qRT-PCR | 22116803 |
RLID00032697 | Exosome | Serum | Next-generation sequencing | 24683445 |
RLID00032698 | Circulating | Serum | Next-generation sequencing | 24577456 |
RLID00032699 | Exosome | Ovarian tumor cell | - | 22529849 |
RLID00032700 | Exosome | Saliva | - | 22529849 |
RLID00032701 | Circulating | Serum | Next-generation sequencing | 22719975 |
RLID00032702 | Exosome | Mast cell | Microarray | 24009880 |